Bastide Le Confort Médical SA
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy. It operates in six segments: Respiratory Assistance, Home Care, Healthcare Facilities, Nutrition/Infusion/Diabetes, Stoma Therapy/Urology/Wound Care, and E-commerce. The company offers reclining chairs… Read more
Bastide Le Confort Médical SA (BLC) - Total Liabilities
Latest total liabilities as of June 2025: €589.73 Million EUR
Based on the latest financial reports, Bastide Le Confort Médical SA (BLC) has total liabilities worth €589.73 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bastide Le Confort Médical SA - Total Liabilities Trend (2008–2025)
This chart illustrates how Bastide Le Confort Médical SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bastide Le Confort Médical SA Competitors by Total Liabilities
The table below lists competitors of Bastide Le Confort Médical SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank Ganesha Tbk PT
JK:BGTG
|
Indonesia | Rp6.59 Trillion |
|
Quarterhill Inc
OTCQX:QTRHF
|
USA | $104.72 Million |
|
enGene Holdings Inc. Warrants
NASDAQ:ENGNW
|
USA | $53.76 Million |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
India | ₹1.53 Billion |
|
Generalplus Technology Inc
TW:4952
|
Taiwan | NT$719.26 Million |
|
QVC Group Inc.
NASDAQ:QVCGB
|
USA | $10.54 Billion |
|
Leadtrend Technology Corp
TW:3588
|
Taiwan | NT$245.96 Million |
|
Emerging Display Technologies Corp
TW:3038
|
Taiwan | NT$1.30 Billion |
Liability Composition Analysis (2008–2025)
This chart breaks down Bastide Le Confort Médical SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bastide Le Confort Médical SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bastide Le Confort Médical SA (2008–2025)
The table below shows the annual total liabilities of Bastide Le Confort Médical SA from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €589.73 Million | +4.13% |
| 2024-06-30 | €566.34 Million | -0.47% |
| 2023-06-30 | €568.99 Million | +4.23% |
| 2022-06-30 | €545.89 Million | +12.77% |
| 2021-06-30 | €484.05 Million | +13.53% |
| 2020-06-30 | €426.38 Million | +29.51% |
| 2019-06-30 | €329.23 Million | +4.62% |
| 2018-06-30 | €314.68 Million | +61.22% |
| 2017-06-30 | €195.19 Million | +50.99% |
| 2016-06-30 | €129.27 Million | +22.73% |
| 2015-06-30 | €105.33 Million | +21.10% |
| 2014-06-30 | €86.98 Million | +26.93% |
| 2013-06-30 | €68.52 Million | +12.46% |
| 2012-06-30 | €60.93 Million | +10.53% |
| 2011-06-30 | €55.12 Million | +24.55% |
| 2010-06-30 | €44.26 Million | +4.18% |
| 2009-06-30 | €42.48 Million | +11.87% |
| 2008-06-30 | €37.98 Million | -- |